Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.70726294 |
2 | negative regulation of cell killing (GO:0031342) | 7.70726294 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.18667173 |
4 | positive thymic T cell selection (GO:0045059) | 5.88433350 |
5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.78328094 |
6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.67834814 |
7 | negative T cell selection (GO:0043383) | 5.61983503 |
8 | negative thymic T cell selection (GO:0045060) | 5.56639128 |
9 | regulation of gamma-delta T cell activation (GO:0046643) | 5.53235720 |
10 | positive T cell selection (GO:0043368) | 5.31881449 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.20722755 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.20722755 |
13 | response to interleukin-15 (GO:0070672) | 5.16479679 |
14 | thymic T cell selection (GO:0045061) | 4.97110649 |
15 | response to peptidoglycan (GO:0032494) | 4.82016216 |
16 | cellular response to interleukin-15 (GO:0071350) | 4.80245408 |
17 | T cell selection (GO:0045058) | 4.75155242 |
18 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.65166997 |
19 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.53955550 |
20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.47658369 |
21 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.34357710 |
22 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.33555380 |
23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.22883967 |
24 | T cell migration (GO:0072678) | 4.20455903 |
25 | T cell receptor signaling pathway (GO:0050852) | 4.19834630 |
26 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.14365800 |
27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.13050808 |
28 | interferon-gamma production (GO:0032609) | 4.07803408 |
29 | macrophage activation involved in immune response (GO:0002281) | 4.02937020 |
30 | modulation by symbiont of host defense response (GO:0052031) | 4.00412812 |
31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.00412812 |
32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.00412812 |
33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.00412812 |
34 | modulation by symbiont of host immune response (GO:0052553) | 4.00412812 |
35 | positive regulation by symbiont of host defense response (GO:0052509) | 4.00412812 |
36 | leukocyte aggregation (GO:0070486) | 4.00215653 |
37 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.97443623 |
38 | germinal center formation (GO:0002467) | 3.96046079 |
39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.86398086 |
40 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.80498207 |
41 | regulation of podosome assembly (GO:0071801) | 3.79880842 |
42 | regulation of T cell tolerance induction (GO:0002664) | 3.78939569 |
43 | response to muramyl dipeptide (GO:0032495) | 3.73800223 |
44 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.71204550 |
45 | regulation of B cell differentiation (GO:0045577) | 3.70103966 |
46 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.62407636 |
47 | T cell costimulation (GO:0031295) | 3.62175713 |
48 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.61529735 |
49 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.58016298 |
50 | regulation of chronic inflammatory response (GO:0002676) | 3.58015315 |
51 | regulation of vitamin metabolic process (GO:0030656) | 3.57211413 |
52 | regulation of interferon-alpha production (GO:0032647) | 3.56751267 |
53 | lymphocyte costimulation (GO:0031294) | 3.56624208 |
54 | defense response to protozoan (GO:0042832) | 3.56137554 |
55 | response to protozoan (GO:0001562) | 3.50811194 |
56 | immunoglobulin mediated immune response (GO:0016064) | 3.49123633 |
57 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.48350263 |
58 | positive regulation of heat generation (GO:0031652) | 3.47207902 |
59 | NIK/NF-kappaB signaling (GO:0038061) | 3.47100211 |
60 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45695619 |
61 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.45313224 |
62 | B cell receptor signaling pathway (GO:0050853) | 3.44353226 |
63 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.37599616 |
64 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36878834 |
65 | regulation of chemokine biosynthetic process (GO:0045073) | 3.36450785 |
66 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.34291985 |
67 | negative regulation of T cell mediated immunity (GO:0002710) | 3.32987102 |
68 | neutrophil activation involved in immune response (GO:0002283) | 3.32519621 |
69 | T-helper 1 type immune response (GO:0042088) | 3.31468840 |
70 | regulation of defense response to virus by virus (GO:0050690) | 3.28913185 |
71 | myeloid dendritic cell differentiation (GO:0043011) | 3.28566421 |
72 | regulation of regulatory T cell differentiation (GO:0045589) | 3.28437678 |
73 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.27825445 |
74 | regulation of fever generation (GO:0031620) | 3.27776586 |
75 | positive regulation of B cell differentiation (GO:0045579) | 3.26865218 |
76 | positive regulation of type 2 immune response (GO:0002830) | 3.23966055 |
77 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23358137 |
78 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.19221442 |
79 | positive regulation of tolerance induction (GO:0002645) | 3.16065582 |
80 | positive regulation of interleukin-2 production (GO:0032743) | 3.15550240 |
81 | mast cell activation (GO:0045576) | 3.14391266 |
82 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.10735881 |
83 | positive regulation of interferon-alpha production (GO:0032727) | 3.10300102 |
84 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.09181081 |
85 | tolerance induction (GO:0002507) | 3.07124272 |
86 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.05457436 |
87 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.05457436 |
88 | positive regulation of histone deacetylation (GO:0031065) | 3.05260150 |
89 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.05077818 |
90 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.04463569 |
91 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03824246 |
92 | T cell homeostasis (GO:0043029) | 3.02639632 |
93 | natural killer cell differentiation (GO:0001779) | 2.99701660 |
94 | response to type I interferon (GO:0034340) | 2.99679965 |
95 | activation of MAPKKK activity (GO:0000185) | 2.99497437 |
96 | activated T cell proliferation (GO:0050798) | 2.96038937 |
97 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.94510724 |
98 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.94005403 |
99 | type I interferon signaling pathway (GO:0060337) | 2.93667414 |
100 | cellular response to type I interferon (GO:0071357) | 2.93667414 |
101 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.92114509 |
102 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.92002275 |
103 | regulation of T-helper cell differentiation (GO:0045622) | 2.91362419 |
104 | detection of molecule of bacterial origin (GO:0032490) | 2.90255616 |
105 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.90124988 |
106 | mannose metabolic process (GO:0006013) | 2.88544407 |
107 | leukocyte cell-cell adhesion (GO:0007159) | 2.88238091 |
108 | regulation of interleukin-12 production (GO:0032655) | 2.87908107 |
109 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.85821361 |
110 | mast cell degranulation (GO:0043303) | 2.85146841 |
111 | mast cell activation involved in immune response (GO:0002279) | 2.85146841 |
112 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.84301613 |
113 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.84097705 |
114 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.83460113 |
115 | regulation of type 2 immune response (GO:0002828) | 2.83205920 |
116 | regulation of tolerance induction (GO:0002643) | 2.82698854 |
117 | detection of other organism (GO:0098543) | 2.82268067 |
118 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.81434662 |
119 | regulation of isotype switching (GO:0045191) | 2.80540375 |
120 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.80422667 |
121 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.80357007 |
122 | natural killer cell activation (GO:0030101) | 2.80261694 |
123 | myeloid dendritic cell activation (GO:0001773) | 2.80213757 |
124 | granulocyte activation (GO:0036230) | 2.79650431 |
125 | modulation by symbiont of host cellular process (GO:0044068) | 2.79151670 |
126 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.78904224 |
127 | positive regulation of isotype switching (GO:0045830) | 2.78497880 |
128 | positive regulation of humoral immune response (GO:0002922) | 2.78424327 |
129 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.78317811 |
130 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.77732627 |
131 | cellular response to lipopolysaccharide (GO:0071222) | 2.75348044 |
132 | positive regulation of granulocyte differentiation (GO:0030854) | 2.73895214 |
133 | regulation of response to interferon-gamma (GO:0060330) | 2.72179915 |
134 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.72101731 |
135 | detection of bacterium (GO:0016045) | 2.70770968 |
136 | cellular response to virus (GO:0098586) | 2.70672563 |
137 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.70616248 |
138 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.70616248 |
139 | negative regulation of innate immune response (GO:0045824) | 2.70416133 |
140 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.70356510 |
141 | cellular response to molecule of bacterial origin (GO:0071219) | 2.70229097 |
142 | positive regulation of Rap GTPase activity (GO:0032854) | 2.70192553 |
143 | T cell differentiation (GO:0030217) | 2.68435492 |
144 | regulation of interleukin-2 production (GO:0032663) | 2.67761405 |
145 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.67616921 |
146 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.67320723 |
147 | lymphocyte homeostasis (GO:0002260) | 2.67265089 |
148 | interferon-gamma secretion (GO:0072643) | 2.66341370 |
149 | response to host immune response (GO:0052572) | 2.65907940 |
150 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65907940 |
151 | positive regulation of lamellipodium assembly (GO:0010592) | 2.64344466 |
152 | myeloid cell activation involved in immune response (GO:0002275) | 2.64037084 |
153 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.63722096 |
154 | regulation of antigen processing and presentation (GO:0002577) | 2.63668128 |
155 | detection of external biotic stimulus (GO:0098581) | 2.61763061 |
156 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.61566982 |
157 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.60172325 |
158 | positive regulation of interferon-beta production (GO:0032728) | 2.59839945 |
159 | mature B cell differentiation (GO:0002335) | 2.59834078 |
160 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.59763385 |
161 | positive regulation of acute inflammatory response (GO:0002675) | 2.59373565 |
162 | positive regulation of interleukin-17 production (GO:0032740) | 2.59197917 |
163 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.58685618 |
164 | negative regulation of interleukin-6 production (GO:0032715) | 2.58521679 |
165 | histone H3-K4 trimethylation (GO:0080182) | 2.57288190 |
166 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.57035754 |
167 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.55541124 |
168 | T cell proliferation (GO:0042098) | 2.55087075 |
169 | regulation of B cell mediated immunity (GO:0002712) | 2.53923742 |
170 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.53650274 |
171 | negative regulation of adaptive immune response (GO:0002820) | 2.51322903 |
172 | alpha-beta T cell activation (GO:0046631) | 2.49998089 |
173 | regulation of cell killing (GO:0031341) | 2.49842359 |
174 | negative regulation of interleukin-12 production (GO:0032695) | 2.48787378 |
175 | T cell activation (GO:0042110) | 2.46970006 |
176 | positive regulation of B cell mediated immunity (GO:0002714) | 2.45787072 |
177 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.45787072 |
178 | leukocyte homeostasis (GO:0001776) | 2.45510083 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.26417637 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.01135018 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 4.29898425 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.92034908 |
5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.22496244 |
6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.21659261 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19620780 |
8 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.10372537 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.90308368 |
10 | * MAF_26560356_Chip-Seq_TH1_Human | 2.88590568 |
11 | UTX_26944678_Chip-Seq_JUKART_Human | 2.84004501 |
12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.80805858 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.80601630 |
14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.80000885 |
15 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.74762673 |
16 | MYB_26560356_Chip-Seq_TH2_Human | 2.69221741 |
17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.68970745 |
18 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.68703838 |
19 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.63252180 |
20 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.63168921 |
21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.58823905 |
22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51031344 |
23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.43054618 |
24 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.42201436 |
25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38505874 |
26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.36516029 |
27 | MYB_26560356_Chip-Seq_TH1_Human | 2.35035533 |
28 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21236610 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.19586186 |
30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.12911684 |
31 | SPI1_23127762_ChIP-Seq_K562_Human | 2.07250271 |
32 | MAF_26560356_Chip-Seq_TH2_Human | 2.02946937 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99551546 |
34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95559430 |
35 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.94976816 |
36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88277579 |
37 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.87187562 |
38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85521307 |
39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84161697 |
40 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.83749202 |
41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79422728 |
42 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.76333049 |
43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75359564 |
44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74940443 |
45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.73096994 |
46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.72588530 |
47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67027782 |
48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.66126831 |
49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.64356990 |
50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62505242 |
51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61628281 |
52 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53619369 |
53 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52213076 |
54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.50205336 |
55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45588259 |
56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.41804190 |
57 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41703377 |
58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40147826 |
59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.38303239 |
60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37066063 |
61 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.35555606 |
62 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34811168 |
63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33866273 |
64 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33716143 |
65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33359772 |
66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32225693 |
67 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30324210 |
68 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28277239 |
69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26837630 |
70 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.26726440 |
71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24484562 |
72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.23144668 |
73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22857758 |
74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22789667 |
75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21727122 |
76 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21651552 |
77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21632905 |
78 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20841317 |
79 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.19434992 |
80 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19268789 |
81 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18010148 |
82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17165664 |
83 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.17139877 |
84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14566790 |
85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13837546 |
86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13137078 |
87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13099138 |
88 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13066680 |
89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12061274 |
90 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11567454 |
91 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.10720543 |
92 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10563955 |
93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09450811 |
94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09124572 |
95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08736832 |
96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07900554 |
97 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07305990 |
98 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07090455 |
99 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05453565 |
100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03588664 |
101 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.02778041 |
102 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.02778041 |
103 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.02778041 |
104 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.02378997 |
105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01941333 |
106 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01940973 |
107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01411066 |
108 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00905077 |
109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00864573 |
110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99680234 |
111 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99615519 |
112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99257027 |
113 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98250262 |
114 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96640563 |
115 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96239285 |
116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96156641 |
117 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95301005 |
118 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95008270 |
119 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94962896 |
120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93276015 |
121 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93144014 |
122 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91290467 |
123 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88156884 |
124 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.87171915 |
125 | P68_20966046_ChIP-Seq_HELA_Human | 0.87102069 |
126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86639042 |
127 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86235521 |
128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83845977 |
129 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.83465755 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 4.51720770 |
2 | MP0005671_abnormal_response_to | 3.74372803 |
3 | MP0000685_abnormal_immune_system | 3.57343511 |
4 | MP0001835_abnormal_antigen_presentation | 3.01834936 |
5 | MP0001800_abnormal_humoral_immune | 2.83511130 |
6 | MP0002396_abnormal_hematopoietic_system | 2.77983034 |
7 | MP0008961_abnormal_basal_metabolism | 2.66939707 |
8 | MP0005387_immune_system_phenotype | 2.61076231 |
9 | MP0001790_abnormal_immune_system | 2.61076231 |
10 | MP0005451_abnormal_body_composition | 2.61057502 |
11 | MP0002398_abnormal_bone_marrow | 2.57901073 |
12 | MP0002420_abnormal_adaptive_immunity | 2.55729645 |
13 | MP0003303_peritoneal_inflammation | 2.54557467 |
14 | MP0001819_abnormal_immune_cell | 2.52802143 |
15 | MP0002166_altered_tumor_susceptibility | 2.51947599 |
16 | MP0002723_abnormal_immune_serum | 2.51137797 |
17 | MP0005000_abnormal_immune_tolerance | 2.50393246 |
18 | MP0000569_abnormal_digit_pigmentation | 2.46898972 |
19 | MP0002452_abnormal_antigen_presenting | 2.36776821 |
20 | MP0000703_abnormal_thymus_morphology | 2.30447444 |
21 | MP0003300_gastrointestinal_ulcer | 2.23014997 |
22 | MP0004510_myositis | 2.18297639 |
23 | MP0002254_reproductive_system_inflammat | 2.17974479 |
24 | MP0000716_abnormal_immune_system | 2.17867932 |
25 | MP0009785_altered_susceptibility_to | 2.17130657 |
26 | MP0005025_abnormal_response_to | 2.13066314 |
27 | MP0009840_abnormal_foam_cell | 2.08845183 |
28 | MP0004859_abnormal_synaptic_plasticity | 2.05571258 |
29 | MP0002405_respiratory_system_inflammati | 2.02489509 |
30 | MP0003436_decreased_susceptibility_to | 2.00283180 |
31 | MP0001873_stomach_inflammation | 1.95735246 |
32 | MP0003172_abnormal_lysosome_physiology | 1.95331925 |
33 | MP0002722_abnormal_immune_system | 1.94432386 |
34 | MP0003866_abnormal_defecation | 1.93955012 |
35 | MP0002006_tumorigenesis | 1.93941888 |
36 | MP0003075_altered_response_to | 1.92320438 |
37 | MP0009764_decreased_sensitivity_to | 1.92279111 |
38 | MP0000689_abnormal_spleen_morphology | 1.88605054 |
39 | MP0008004_abnormal_stomach_pH | 1.87952894 |
40 | MP0003183_abnormal_peptide_metabolism | 1.82913318 |
41 | MP0004808_abnormal_hematopoietic_stem | 1.79096925 |
42 | MP0002419_abnormal_innate_immunity | 1.77787026 |
43 | MP0009278_abnormal_bone_marrow | 1.76944185 |
44 | MP0005464_abnormal_platelet_physiology | 1.76653275 |
45 | MP0002429_abnormal_blood_cell | 1.76445905 |
46 | MP0009333_abnormal_splenocyte_physiolog | 1.75654342 |
47 | MP0004947_skin_inflammation | 1.75056684 |
48 | MP0010155_abnormal_intestine_physiology | 1.72620773 |
49 | MP0006082_CNS_inflammation | 1.70343403 |
50 | MP0002933_joint_inflammation | 1.66369106 |
51 | MP0005174_abnormal_tail_pigmentation | 1.61432060 |
52 | MP0005167_abnormal_blood-brain_barrier | 1.58729084 |
53 | MP0003453_abnormal_keratinocyte_physiol | 1.57020999 |
54 | MP0000343_altered_response_to | 1.40351466 |
55 | MP0001845_abnormal_inflammatory_respons | 1.35745751 |
56 | MP0002332_abnormal_exercise_endurance | 1.35157137 |
57 | MP0008260_abnormal_autophagy | 1.34550082 |
58 | MP0002148_abnormal_hypersensitivity_rea | 1.30208560 |
59 | MP0002909_abnormal_adrenal_gland | 1.25015429 |
60 | MP0003191_abnormal_cellular_cholesterol | 1.23938357 |
61 | MP0005423_abnormal_somatic_nervous | 1.23358286 |
62 | MP0000465_gastrointestinal_hemorrhage | 1.22620385 |
63 | MP0005166_decreased_susceptibility_to | 1.21792439 |
64 | MP0003724_increased_susceptibility_to | 1.20515603 |
65 | MP0003787_abnormal_imprinting | 1.15199004 |
66 | MP0001545_abnormal_hematopoietic_system | 1.14884725 |
67 | MP0005397_hematopoietic_system_phenotyp | 1.14884725 |
68 | MP0005076_abnormal_cell_differentiation | 1.10479118 |
69 | MP0008569_lethality_at_weaning | 1.09927749 |
70 | MP0005390_skeleton_phenotype | 1.09407988 |
71 | MP0005075_abnormal_melanosome_morpholog | 1.08370773 |
72 | MP0003690_abnormal_glial_cell | 1.07857871 |
73 | MP0000015_abnormal_ear_pigmentation | 1.06298954 |
74 | MP0003705_abnormal_hypodermis_morpholog | 1.06044171 |
75 | MP0002139_abnormal_hepatobiliary_system | 1.05058509 |
76 | MP0003122_maternal_imprinting | 0.98586918 |
77 | MP0000858_altered_metastatic_potential | 0.97503761 |
78 | MP0001663_abnormal_digestive_system | 0.96239516 |
79 | MP0000678_abnormal_parathyroid_gland | 0.94974931 |
80 | MP0002998_abnormal_bone_remodeling | 0.94506887 |
81 | MP0005310_abnormal_salivary_gland | 0.92700037 |
82 | MP0000371_diluted_coat_color | 0.92604377 |
83 | MP0003635_abnormal_synaptic_transmissio | 0.90008798 |
84 | MP0001853_heart_inflammation | 0.86421535 |
85 | MP0004130_abnormal_muscle_cell | 0.86342035 |
86 | MP0003656_abnormal_erythrocyte_physiolo | 0.85422361 |
87 | MP0001533_abnormal_skeleton_physiology | 0.85185532 |
88 | MP0001851_eye_inflammation | 0.84608378 |
89 | MP0000490_abnormal_crypts_of | 0.83804929 |
90 | MP0003279_aneurysm | 0.83429458 |
91 | MP0002138_abnormal_hepatobiliary_system | 0.80815083 |
92 | MP0005666_abnormal_adipose_tissue | 0.79627222 |
93 | MP0006054_spinal_hemorrhage | 0.79386867 |
94 | MP0005164_abnormal_response_to | 0.79217228 |
95 | MP0005645_abnormal_hypothalamus_physiol | 0.77426236 |
96 | MP0002095_abnormal_skin_pigmentation | 0.76034052 |
97 | MP0008469_abnormal_protein_level | 0.75567485 |
98 | MP0002693_abnormal_pancreas_physiology | 0.75085362 |
99 | MP0009763_increased_sensitivity_to | 0.75077161 |
100 | MP0003091_abnormal_cell_migration | 0.73240767 |
101 | MP0004811_abnormal_neuron_physiology | 0.73060355 |
102 | MP0005023_abnormal_wound_healing | 0.72683692 |
103 | MP0002089_abnormal_postnatal_growth/wei | 0.72561658 |
104 | MP0003448_altered_tumor_morphology | 0.72167251 |
105 | MP0003828_pulmonary_edema | 0.71418349 |
106 | MP0002928_abnormal_bile_duct | 0.71118085 |
107 | MP0003806_abnormal_nucleotide_metabolis | 0.70368787 |
108 | MP0002019_abnormal_tumor_incidence | 0.69852128 |
109 | MP0009765_abnormal_xenobiotic_induced | 0.67973945 |
110 | MP0000249_abnormal_blood_vessel | 0.67956360 |
111 | MP0004185_abnormal_adipocyte_glucose | 0.67929925 |
112 | MP0003329_amyloid_beta_deposits | 0.67552150 |
113 | MP0002877_abnormal_melanocyte_morpholog | 0.67122262 |
114 | MP0003045_fibrosis | 0.65936179 |
115 | MP0001348_abnormal_lacrimal_gland | 0.65105637 |
116 | MP0004858_abnormal_nervous_system | 0.64887807 |
117 | MP0005381_digestive/alimentary_phenotyp | 0.63962602 |
118 | MP0005375_adipose_tissue_phenotype | 0.62887124 |
119 | MP0003121_genomic_imprinting | 0.62556765 |
120 | MP0002277_abnormal_respiratory_mucosa | 0.61380020 |
121 | MP0004883_abnormal_blood_vessel | 0.58369682 |
122 | MP0005058_abnormal_lysosome_morphology | 0.57287391 |
123 | MP0003959_abnormal_lean_body | 0.56114873 |
124 | MP0003646_muscle_fatigue | 0.55174797 |
125 | MP0000767_abnormal_smooth_muscle | 0.55100564 |
126 | MP0002063_abnormal_learning/memory/cond | 0.55026902 |
127 | MP0008770_decreased_survivor_rate | 0.53838692 |
128 | MP0001502_abnormal_circadian_rhythm | 0.52916314 |
129 | MP0002083_premature_death | 0.52319049 |
130 | MP0008874_decreased_physiological_sensi | 0.47572596 |
131 | MP0010352_gastrointestinal_tract_polyps | 0.44429684 |
132 | MP0000604_amyloidosis | 0.44040485 |
133 | MP0001944_abnormal_pancreas_morphology | 0.43125250 |
134 | MP0002075_abnormal_coat/hair_pigmentati | 0.42767926 |
135 | MP0003795_abnormal_bone_structure | 0.42425428 |
136 | MP0000477_abnormal_intestine_morphology | 0.41663153 |
137 | MP0001849_ear_inflammation | 0.41487003 |
138 | MP0002557_abnormal_social/conspecific_i | 0.40851509 |
139 | MP0009745_abnormal_behavioral_response | 0.40346278 |
140 | MP0002822_catalepsy | 0.40095958 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.77295766 |
2 | T lymphocytopenia (HP:0005403) | 4.69124031 |
3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.63843234 |
4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.63843234 |
5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.63843234 |
6 | Abnormality of macrophages (HP:0004311) | 4.50414875 |
7 | Abnormality of T cell number (HP:0011839) | 4.43491496 |
8 | Recurrent bronchitis (HP:0002837) | 4.01112640 |
9 | Severe combined immunodeficiency (HP:0004430) | 3.91070744 |
10 | Recurrent fungal infections (HP:0002841) | 3.79727247 |
11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.77877159 |
12 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.77877159 |
13 | Dysostosis multiplex (HP:0000943) | 3.69596177 |
14 | Abnormality of the fingertips (HP:0001211) | 3.67022243 |
15 | Panhypogammaglobulinemia (HP:0003139) | 3.66263061 |
16 | Abnormality of T cells (HP:0002843) | 3.54027862 |
17 | Increased cerebral lipofuscin (HP:0011813) | 3.53142518 |
18 | Stomatitis (HP:0010280) | 3.51344551 |
19 | Thyroiditis (HP:0100646) | 3.44889775 |
20 | Loss of speech (HP:0002371) | 3.38926711 |
21 | Myositis (HP:0100614) | 3.38726102 |
22 | Recurrent viral infections (HP:0004429) | 3.38080661 |
23 | Combined immunodeficiency (HP:0005387) | 3.33995404 |
24 | Chronic otitis media (HP:0000389) | 3.33195190 |
25 | Systemic lupus erythematosus (HP:0002725) | 3.29920036 |
26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.27075019 |
27 | IgM deficiency (HP:0002850) | 3.25811613 |
28 | Hyperacusis (HP:0010780) | 3.19216973 |
29 | Keratoconjunctivitis sicca (HP:0001097) | 3.14705263 |
30 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.13142279 |
31 | Nasal polyposis (HP:0100582) | 3.01103475 |
32 | Gastrointestinal infarctions (HP:0005244) | 2.93547050 |
33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.93001514 |
34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.88981015 |
35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.88981015 |
36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.88981015 |
37 | Eczematoid dermatitis (HP:0000976) | 2.83355995 |
38 | Chronic diarrhea (HP:0002028) | 2.82225806 |
39 | Vacuolated lymphocytes (HP:0001922) | 2.81938502 |
40 | Keratoconjunctivitis (HP:0001096) | 2.80081511 |
41 | Interstitial pulmonary disease (HP:0006530) | 2.78105341 |
42 | Increased IgM level (HP:0003496) | 2.77997138 |
43 | Abnormality of the nasal mucosa (HP:0000433) | 2.75230316 |
44 | Hypoplasia of the thymus (HP:0000778) | 2.74561211 |
45 | Agammaglobulinemia (HP:0004432) | 2.73939829 |
46 | Nuclear cataract (HP:0100018) | 2.73117079 |
47 | Increased serum ferritin (HP:0003281) | 2.71943414 |
48 | Mucopolysacchariduria (HP:0008155) | 2.71648773 |
49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71648773 |
50 | Abnormality of B cell number (HP:0010975) | 2.71297115 |
51 | B lymphocytopenia (HP:0010976) | 2.71297115 |
52 | IgG deficiency (HP:0004315) | 2.66878805 |
53 | Gastrointestinal inflammation (HP:0004386) | 2.66331536 |
54 | Disinhibition (HP:0000734) | 2.62024816 |
55 | Abnormality of eosinophils (HP:0001879) | 2.61927862 |
56 | Recurrent abscess formation (HP:0002722) | 2.60490676 |
57 | Inflammation of the large intestine (HP:0002037) | 2.59564160 |
58 | Lymphopenia (HP:0001888) | 2.58622981 |
59 | Mediastinal lymphadenopathy (HP:0100721) | 2.58024058 |
60 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.51109301 |
61 | Neurofibrillary tangles (HP:0002185) | 2.44285548 |
62 | Thin bony cortex (HP:0002753) | 2.44069377 |
63 | Purpura (HP:0000979) | 2.40129976 |
64 | Amyloidosis (HP:0011034) | 2.36678247 |
65 | Hemoptysis (HP:0002105) | 2.35683853 |
66 | Macroorchidism (HP:0000053) | 2.33245400 |
67 | Meningitis (HP:0001287) | 2.32798164 |
68 | Recurrent skin infections (HP:0001581) | 2.32592768 |
69 | Abnormality of T cell physiology (HP:0011840) | 2.32316363 |
70 | Encephalitis (HP:0002383) | 2.32047063 |
71 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.31630505 |
72 | Leukocytosis (HP:0001974) | 2.30952814 |
73 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.24750537 |
74 | Spinal canal stenosis (HP:0003416) | 2.24513657 |
75 | Chest pain (HP:0100749) | 2.24247551 |
76 | Amyotrophic lateral sclerosis (HP:0007354) | 2.22582725 |
77 | Gangrene (HP:0100758) | 2.19661396 |
78 | Hypertensive crisis (HP:0100735) | 2.18153927 |
79 | Acne (HP:0001061) | 2.17402310 |
80 | Frequent falls (HP:0002359) | 2.16948431 |
81 | Thoracic kyphosis (HP:0002942) | 2.16756976 |
82 | Basal cell carcinoma (HP:0002671) | 2.15564997 |
83 | Thrombocytosis (HP:0001894) | 2.14682612 |
84 | Abnormality of the endocardium (HP:0004306) | 2.14022219 |
85 | Glomerulonephritis (HP:0000099) | 2.12747374 |
86 | Optic neuritis (HP:0100653) | 2.12398598 |
87 | Retrobulbar optic neuritis (HP:0100654) | 2.12398598 |
88 | Hematochezia (HP:0002573) | 2.11321890 |
89 | Colitis (HP:0002583) | 2.11013235 |
90 | Neuronal loss in central nervous system (HP:0002529) | 2.10787509 |
91 | Mutism (HP:0002300) | 2.10112722 |
92 | Large eyes (HP:0001090) | 2.09272189 |
93 | Polygenic inheritance (HP:0010982) | 2.08181547 |
94 | Anorexia (HP:0002039) | 2.07990838 |
95 | Episodic fever (HP:0001954) | 2.07958497 |
96 | Elfin facies (HP:0004428) | 2.07226848 |
97 | Autoimmune thrombocytopenia (HP:0001973) | 2.06972436 |
98 | Abnormality of iron homeostasis (HP:0011031) | 2.05964701 |
99 | Vasculitis (HP:0002633) | 2.05626606 |
100 | Prolonged bleeding time (HP:0003010) | 2.05017000 |
101 | Axonal loss (HP:0003447) | 2.04730430 |
102 | Urticaria (HP:0001025) | 2.04002451 |
103 | Progressive neurologic deterioration (HP:0002344) | 2.03240139 |
104 | Recurrent bacterial skin infections (HP:0005406) | 2.02868310 |
105 | Pustule (HP:0200039) | 2.00761987 |
106 | Increased IgE level (HP:0003212) | 2.00655395 |
107 | Orchitis (HP:0100796) | 1.99559109 |
108 | Increased density of long bones (HP:0006392) | 1.98614885 |
109 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.98574321 |
110 | Bronchitis (HP:0012387) | 1.98541476 |
111 | Abnormality of the pleura (HP:0002103) | 1.97242206 |
112 | Eosinophilia (HP:0001880) | 1.96832235 |
113 | Apathy (HP:0000741) | 1.96080255 |
114 | Cerebral aneurysm (HP:0004944) | 1.94915898 |
115 | Pulmonary infiltrates (HP:0002113) | 1.94818412 |
116 | Papilloma (HP:0012740) | 1.93411870 |
117 | Verrucae (HP:0200043) | 1.93411870 |
118 | Diminished motivation (HP:0000745) | 1.93206544 |
119 | Pulmonary embolism (HP:0002204) | 1.91818872 |
120 | Petechiae (HP:0000967) | 1.91149115 |
121 | Cerebral inclusion bodies (HP:0100314) | 1.90662935 |
122 | Hepatosplenomegaly (HP:0001433) | 1.90365151 |
123 | Poikiloderma (HP:0001029) | 1.89653448 |
124 | Chronic sinusitis (HP:0011109) | 1.89481077 |
125 | Pointed chin (HP:0000307) | 1.89102058 |
126 | Deep palmar crease (HP:0006191) | 1.88166269 |
127 | Recurrent sinusitis (HP:0011108) | 1.88134378 |
128 | Acute lymphatic leukemia (HP:0006721) | 1.87969337 |
129 | Emphysema (HP:0002097) | 1.87931386 |
130 | Restrictive lung disease (HP:0002091) | 1.87170220 |
131 | Cellulitis (HP:0100658) | 1.86584925 |
132 | Insomnia (HP:0100785) | 1.86376268 |
133 | Gingivitis (HP:0000230) | 1.83622271 |
134 | Autoimmune hemolytic anemia (HP:0001890) | 1.81808655 |
135 | Obstructive sleep apnea (HP:0002870) | 1.81057268 |
136 | Arthralgia (HP:0002829) | 1.81007877 |
137 | Abnormality of the thoracic spine (HP:0100711) | 1.79340840 |
138 | Arterial thrombosis (HP:0004420) | 1.78536516 |
139 | Joint swelling (HP:0001386) | 1.77952824 |
140 | Cheilitis (HP:0100825) | 1.77520942 |
141 | Hypergammaglobulinemia (HP:0010702) | 1.77182649 |
142 | Heterotopia (HP:0002282) | 1.76124102 |
143 | Papilledema (HP:0001085) | 1.75824153 |
144 | Spontaneous hematomas (HP:0007420) | 1.74257776 |
145 | Bicuspid aortic valve (HP:0001647) | 1.73758728 |
146 | Gastrointestinal stroma tumor (HP:0100723) | 1.73163587 |
147 | Striae distensae (HP:0001065) | 1.72974370 |
148 | Lymphoma (HP:0002665) | 1.72355389 |
149 | Ureteral stenosis (HP:0000071) | 1.71466965 |
150 | Fatigue (HP:0012378) | 1.71109539 |
151 | Neoplasm of the heart (HP:0100544) | 1.70266922 |
152 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.68565943 |
153 | Urinary urgency (HP:0000012) | 1.68270178 |
154 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.68109219 |
155 | IgA deficiency (HP:0002720) | 1.66845870 |
156 | Obsessive-compulsive behavior (HP:0000722) | 1.65208357 |
157 | Obstructive lung disease (HP:0006536) | 1.64884369 |
158 | Chronic obstructive pulmonary disease (HP:0006510) | 1.64884369 |
159 | Broad palm (HP:0001169) | 1.64343186 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.73158201 |
2 | IRAK3 | 4.13608742 |
3 | TXK | 3.56695118 |
4 | PRPF4B | 2.99545779 |
5 | FGFR4 | 2.89116150 |
6 | JAK3 | 2.76547382 |
7 | NME2 | 2.68996854 |
8 | SIK2 | 2.58436054 |
9 | MAP3K10 | 2.55726073 |
10 | ZAP70 | 2.46078660 |
11 | TAOK2 | 2.42505446 |
12 | IKBKE | 2.38511668 |
13 | MAP3K11 | 2.26711836 |
14 | KIT | 2.23856951 |
15 | TYK2 | 2.21838038 |
16 | ITK | 2.19894845 |
17 | EEF2K | 2.17556313 |
18 | MAP2K3 | 2.03099312 |
19 | SMG1 | 2.00504173 |
20 | MATK | 1.97943382 |
21 | TRIB3 | 1.95703907 |
22 | PKN2 | 1.93024679 |
23 | DDR2 | 1.88814938 |
24 | TBK1 | 1.83722473 |
25 | FGFR3 | 1.80037234 |
26 | JAK1 | 1.79793973 |
27 | SIK3 | 1.73912058 |
28 | FLT3 | 1.70158019 |
29 | CDC42BPA | 1.67477165 |
30 | MAP3K3 | 1.60908103 |
31 | FGR | 1.57135177 |
32 | SYK | 1.51408666 |
33 | GRK6 | 1.50058062 |
34 | LCK | 1.46994357 |
35 | CSF1R | 1.45871643 |
36 | NTRK2 | 1.45115479 |
37 | MAP3K13 | 1.44072830 |
38 | HCK | 1.44062257 |
39 | GRK7 | 1.41197790 |
40 | MARK2 | 1.38615996 |
41 | BTK | 1.36199980 |
42 | FES | 1.34189917 |
43 | MARK1 | 1.33718481 |
44 | IRAK4 | 1.33603773 |
45 | ERN1 | 1.30785634 |
46 | MAP3K1 | 1.28858510 |
47 | PRKCH | 1.26984304 |
48 | TYRO3 | 1.25141519 |
49 | NLK | 1.24670424 |
50 | MAP3K7 | 1.23757100 |
51 | RIPK1 | 1.16303645 |
52 | PIM2 | 1.08124510 |
53 | CSK | 1.05177906 |
54 | TGFBR2 | 1.04884533 |
55 | TEC | 1.03956066 |
56 | CAMK1G | 1.03375836 |
57 | TAOK1 | 1.00588713 |
58 | HIPK2 | 0.98715430 |
59 | MOS | 0.97511388 |
60 | MAP3K14 | 0.95597512 |
61 | BLK | 0.94566269 |
62 | RIPK4 | 0.88993917 |
63 | MARK3 | 0.86542101 |
64 | SIK1 | 0.86314641 |
65 | KDR | 0.85497907 |
66 | JAK2 | 0.84099242 |
67 | TNK2 | 0.83892294 |
68 | STK10 | 0.83524165 |
69 | TNIK | 0.77140747 |
70 | PDGFRB | 0.77068558 |
71 | BRD4 | 0.74301192 |
72 | RET | 0.71991330 |
73 | RPS6KL1 | 0.71202550 |
74 | RPS6KC1 | 0.71202550 |
75 | PDGFRA | 0.70829088 |
76 | BMX | 0.68431203 |
77 | TTN | 0.68097610 |
78 | PRKD2 | 0.65848284 |
79 | LYN | 0.65667302 |
80 | CAMK1D | 0.65552122 |
81 | SCYL2 | 0.65188186 |
82 | PTK6 | 0.64061471 |
83 | TGFBR1 | 0.62287782 |
84 | MAP3K9 | 0.61596285 |
85 | DAPK1 | 0.60952161 |
86 | UHMK1 | 0.60240977 |
87 | ALK | 0.58050973 |
88 | RPS6KA6 | 0.57066093 |
89 | CHUK | 0.56722296 |
90 | MAP2K6 | 0.56150720 |
91 | PDPK1 | 0.56061216 |
92 | PRKCQ | 0.55290150 |
93 | BMPR2 | 0.55183949 |
94 | PASK | 0.54917462 |
95 | ARAF | 0.54471814 |
96 | CAMKK1 | 0.54085867 |
97 | EPHB1 | 0.53452225 |
98 | LRRK2 | 0.53399052 |
99 | CLK1 | 0.53136139 |
100 | IKBKB | 0.51423492 |
101 | PDK1 | 0.50913368 |
102 | KSR2 | 0.50704995 |
103 | FYN | 0.50507844 |
104 | CAMKK2 | 0.49668847 |
105 | DMPK | 0.48591244 |
106 | CDK4 | 0.47840723 |
107 | TESK2 | 0.47323695 |
108 | CDK12 | 0.46335608 |
109 | MAP3K5 | 0.45542682 |
110 | DAPK2 | 0.45396038 |
111 | FGFR2 | 0.45296531 |
112 | MAP3K12 | 0.44874509 |
113 | MAPK7 | 0.44051002 |
114 | CAMK1 | 0.43273524 |
115 | EPHA3 | 0.42864082 |
116 | DYRK3 | 0.42726055 |
117 | DYRK1B | 0.42182108 |
118 | MAPK12 | 0.41690201 |
119 | PIM1 | 0.41593087 |
120 | MAPK11 | 0.41121818 |
121 | IRAK1 | 0.37899584 |
122 | MAPK4 | 0.34622338 |
123 | ICK | 0.34399048 |
124 | IRAK2 | 0.34351261 |
125 | ABL2 | 0.34161800 |
126 | CAMK4 | 0.33811228 |
127 | MTOR | 0.33549589 |
128 | MAPK9 | 0.32633336 |
129 | CDK5 | 0.32310563 |
130 | RPS6KA1 | 0.31984646 |
131 | MAPK13 | 0.30770116 |
132 | KSR1 | 0.30583856 |
133 | TAOK3 | 0.28669016 |
134 | RPS6KA2 | 0.28498284 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.54403286 |
2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.60957677 |
3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.23151684 |
4 | Malaria_Homo sapiens_hsa05144 | 2.18106525 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06631600 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93932780 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88278401 |
8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87224722 |
9 | Measles_Homo sapiens_hsa05162 | 1.84415937 |
10 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.81635814 |
11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.76557549 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.72999616 |
13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71769155 |
14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69942354 |
15 | Asthma_Homo sapiens_hsa05310 | 1.69745563 |
16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63259116 |
17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62086637 |
18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.55449758 |
19 | Lysosome_Homo sapiens_hsa04142 | 1.52104228 |
20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50299454 |
21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42662138 |
22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42481689 |
23 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.37400868 |
24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36651001 |
25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35373538 |
26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33989294 |
27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33716396 |
28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.33629596 |
29 | Colorectal cancer_Homo sapiens_hsa05210 | 1.33404843 |
30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32251284 |
31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31984467 |
32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31876829 |
33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31778177 |
34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25924029 |
35 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.22046746 |
36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21678187 |
37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19664745 |
38 | Bladder cancer_Homo sapiens_hsa05219 | 1.17418897 |
39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16285150 |
40 | Hepatitis B_Homo sapiens_hsa05161 | 1.16042390 |
41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.15739687 |
42 | Prion diseases_Homo sapiens_hsa05020 | 1.14350762 |
43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13627340 |
44 | Shigellosis_Homo sapiens_hsa05131 | 1.11899518 |
45 | Allograft rejection_Homo sapiens_hsa05330 | 1.11084044 |
46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.09218127 |
47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08073632 |
48 | Influenza A_Homo sapiens_hsa05164 | 1.07514466 |
49 | Platelet activation_Homo sapiens_hsa04611 | 1.06110826 |
50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05349506 |
51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04430467 |
52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04016434 |
53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02834372 |
54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99623843 |
55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99432877 |
56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98394044 |
57 | Amoebiasis_Homo sapiens_hsa05146 | 0.96384731 |
58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96189052 |
59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95303346 |
60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94251579 |
61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.90074540 |
62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89533072 |
63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.88121610 |
64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88089938 |
65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.86631179 |
66 | Tuberculosis_Homo sapiens_hsa05152 | 0.85932108 |
67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85928998 |
68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84222752 |
69 | Apoptosis_Homo sapiens_hsa04210 | 0.83444167 |
70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81600193 |
71 | Phagosome_Homo sapiens_hsa04145 | 0.80026496 |
72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78378453 |
73 | Salmonella infection_Homo sapiens_hsa05132 | 0.77253661 |
74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76876305 |
75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76212755 |
76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74421184 |
77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72872598 |
78 | Long-term potentiation_Homo sapiens_hsa04720 | 0.72777257 |
79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71934679 |
80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71826995 |
81 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71779255 |
82 | Glioma_Homo sapiens_hsa05214 | 0.71479456 |
83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70144649 |
84 | Morphine addiction_Homo sapiens_hsa05032 | 0.70098089 |
85 | Hepatitis C_Homo sapiens_hsa05160 | 0.69495749 |
86 | Endocytosis_Homo sapiens_hsa04144 | 0.69159197 |
87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69133831 |
88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68770362 |
89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67853341 |
90 | Insulin resistance_Homo sapiens_hsa04931 | 0.67433050 |
91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66412020 |
92 | Pertussis_Homo sapiens_hsa05133 | 0.66160573 |
93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.64423803 |
94 | Circadian entrainment_Homo sapiens_hsa04713 | 0.64275314 |
95 | Insulin secretion_Homo sapiens_hsa04911 | 0.64217786 |
96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63408430 |
97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62480140 |
98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61981039 |
99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61941602 |
100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61553130 |
101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61233221 |
102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61084420 |
103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56448476 |
104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56444768 |
105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55628705 |
106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54482019 |
107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54414803 |
108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53412852 |
109 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52290728 |
110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51215906 |
111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51101691 |
112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50730238 |
113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49202284 |
114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49090995 |
115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48337247 |
116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48119262 |
117 | Legionellosis_Homo sapiens_hsa05134 | 0.47452856 |
118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47424484 |
119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47311193 |
120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45268774 |
121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44939949 |
122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38363226 |
123 | Prostate cancer_Homo sapiens_hsa05215 | 0.36712682 |
124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31514989 |
125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29777174 |